Blueprint Medicines Funding: $115M Raised, Series C (2014)

Blueprint Medicines funding overview

Blueprint Medicines is a Biotech company based in Cambridge, Massachusetts. Blueprint Medicines has raised $115M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in November 2014. The round record for Blueprint Medicines runs through 2014; nothing later has been disclosed. Investors on record include BVF Partners, Casdin Capital, Cowen Healthcare Investments, F-Prime Capital, Nextech Invest, Perceptive Advisors and 6 others. 12 distinct backers are named across the disclosed rounds.

Blueprint Medicines at a glance

Total raised: $115M
Latest round: Series C
Latest round date: November 2014
Industry: Biotech
Headquarters: Cambridge, Massachusetts
Notable investors: BVF Partners, Casdin Capital, Cowen Healthcare Investments, F-Prime Capital, Nextech Invest, Perceptive Advisors, RA Capital Management, Redmile Group

Frequently asked about Blueprint Medicines funding

How much has Blueprint Medicines raised?: Blueprint Medicines has raised $115M in total disclosed funding across the rounds on record.
Who has invested in Blueprint Medicines?: BVF Partners, Casdin Capital, Cowen Healthcare Investments, F-Prime Capital, Nextech Invest, Perceptive Advisors are named among the investors backing Blueprint Medicines.
What was the latest Blueprint Medicines funding round?: The most recent disclosed round is a Series C, announced in November 2014.
Where is Blueprint Medicines based?: Blueprint Medicines is based in Cambridge, Massachusetts.
What sector does Blueprint Medicines operate in?: Blueprint Medicines is tracked under Biotech from Cambridge, Massachusetts, with $115M in disclosed funding.
When did Blueprint Medicines last raise?: The last disclosed Blueprint Medicines round closed in November 2014 at Series C.

Blueprint Medicines totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Cambridge below to benchmark round size and investor mix.

Blueprint Medicines Funding: $115M Raised, Series C (2014)

Blueprint Medicines funding overview

Blueprint Medicines at a glance

Frequently asked about Blueprint Medicines funding

Companies related to Blueprint Medicines (40)

Browse related funding lists (10)